Publisher Correction: Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1

Nat Cancer. 2020 Sep;1(9):935. doi: 10.1038/s43018-020-00118-z.

Rodrigo Romero^#^{1

2}, Francisco J Sánchez-Rivera^#^{1

2

3}, Peter M K Westcott¹, Kim L Mercer^{1

4}, Arjun Bhutkar¹, Alexander Muir^{1

5}, Tania J González Robles¹, Swanny Lamboy Rodríguez², Laura Z Liao², Sheng Rong Ng^{1

2}, Leanne Li¹, Caterina I Colón¹, Santiago Naranjo^{1

2}, Mary Clare Beytagh², Caroline A Lewis⁶, Peggy P Hsu^{1

7

8}, Roderick T Bronson^{9

10}, Matthew G Vander Heiden^{1

2

8}, Tyler Jacks^{11

12

13}

¹ Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.
² Massachusetts Institute of Technology Department of Biology, Cambridge, MA, USA.
³ Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁴ Howard Hughes Medical Institute, Chevy Chase, MD, USA.
⁵ Ben May Department for Cancer Research, University of Chicago, Chicago, IL, USA.
⁶ Whitehead Institute, Massachusetts Institute of Technology, Cambridge, MA, USA.
⁷ Massachusetts General Hospital Cancer Center, Boston, MA, USA.
⁸ Dana-Farber Cancer Institute, Boston, MA, USA.
⁹ Tufts University, Boston, MA, USA.
¹⁰ Harvard Medical School, Boston, MA, USA.
¹¹ Koch Institute for Integrative Cancer Research, Cambridge, MA, USA. tjacks@mit.edu.
¹² Massachusetts Institute of Technology Department of Biology, Cambridge, MA, USA. tjacks@mit.edu.
¹³ Howard Hughes Medical Institute, Chevy Chase, MD, USA. tjacks@mit.edu.

^# Contributed equally.

No abstract available

Publication types